TABLE 3.
β-Lactam | MIC (μg/ml)
|
|||
---|---|---|---|---|
ATCC 13182Ta | SC 10,436b | SG266 | SG271 | |
Amoxicillin | 128 | >1,024 | 64 | 16 |
+ 2 μg of clavulanate/ml | 1 | 128 | 0.5 | 0.25 |
Ticarcillin | 32 | >1,024 | 64 | 16 |
+ 2 μg of clavulanate/ml | 1 | 256 | 2 | 0.5 |
Piperacillin | 2 | 512 | 2 | 1 |
+ 4 μg of tazobactam/ml | 0.5 | 256 | 0.5 | 0.12 |
Cephalothin | 2 | 64 | 2 | 2 |
Cefoxitin | 0.5 | 1 | 1 | 0.5 |
Cefotaxime | ≤0.06 | 2 | ≤0.06 | ≤0.06 |
Ceftazidime | 0.12 | 1 | ≤0.06 | ≤0.06 |
Cefepime | ≤0.06 | 2 | ≤0.06 | ≤0.06 |
Aztreonam | ≤0.06 | 32 | ≤0.06 | ≤0.06 |
Imipenem | 0.5 | 0.5 | 0.5 | 0.5 |
Strain ATCC 13182T (14) harboring a blaOXY-2 gene under the control of a wild type promoter.
Strain SC 10,436 (12) harboring a blaOXY-2 gene under the control of a mutated promoter responsible for the β-lactamase overproduction.